BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2904564)

  • 1. Pelvic irradiation and tamoxifen as risk factors for carcinoma of corpus uteri.
    Hardell L
    Lancet; 1988 Dec; 2(8625):1432. PubMed ID: 2904564
    [No Abstract]   [Full Text] [Related]  

  • 2. Postradiation carcinosarcoma of the corpus uteri--a case report.
    Zwierzchowska A; Panek G; Gajewska M
    Eur J Gynaecol Oncol; 2015; 36(6):746-9. PubMed ID: 26775366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen as risk factor for carcinoma of corpus uteri.
    Hardell L
    Lancet; 1988 Sep; 2(8610):563. PubMed ID: 2900934
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenomyomatous polyp of the uterus in a patient receiving tamoxifen.
    Nasu K; Arima K; Yoshimatsu J; Miyakawa I
    Jpn J Clin Oncol; 1997 Oct; 27(5):350-2. PubMed ID: 9390216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Explosive growth of uterine leiomyomas and carcinologic ovarian risk in a non-menopausal patient with BRCA1-BRCA2 mutation treated by tamoxifen].
    Doridot V; This P; Clough KB
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7):677-80. PubMed ID: 12457141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen-induced growth of leiomyomas. A case report.
    Kang J; Baxi L; Heller D
    J Reprod Med; 1996 Feb; 41(2):119-20. PubMed ID: 8656411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2 rare cases of a presentation of endometrial cancer].
    Capurro I; Jorquera J; Rojo JA; Wistuba I
    Rev Chil Obstet Ginecol; 1992; 57(5):351-5. PubMed ID: 1342466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increase in risk of endometrial carcinoma following treatment of breast carcinoma with tamoxifen].
    Dijkhuizen FP; Brölmann HA; Roumen RM; Bastin FH; Heintz AP
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2393. PubMed ID: 7501085
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases.
    Yildirim Y; Inal MM; Sanci M; Yildirim YK; Mit T; Polat M; Tinar S
    Int J Gynecol Cancer; 2005; 15(6):1239-42. PubMed ID: 16343223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uterine sarcoma associated with tamoxifen use after breast cancer: Review of the pathogenesis].
    Homer L; Muller M; Dupré PF; Lucas B; Pradier O
    J Gynecol Obstet Biol Reprod (Paris); 2009 Dec; 38(8):629-33. PubMed ID: 19833452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case of uterine papillary serous carcinoma following tamoxifen treatment that could not be diagnosed during screening.
    Maenaka T; Egawa-Takata T; Hisamoto K; Kunishige I; Nishio Y; Tsujimoto M
    J Obstet Gynaecol Res; 2014 May; 40(5):1450-4. PubMed ID: 24606575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal pure rhabdomyosarcoma of the uterine corpus associated with previous pelvic irradiation.
    Leung F; Terzibachian JJ; Govyadovskiy A; Lassabe C
    Arch Gynecol Obstet; 2009 Feb; 279(2):209-11. PubMed ID: 18461344
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
    Suprasert P; Khunamornpong S
    J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri.
    Onsrud M; Hagen B; Strickert T
    Gynecol Oncol; 2001 Jul; 82(1):167-71. PubMed ID: 11426980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen-related uterine malignancies: carcinomas or sarcomas?
    Delaloge S; Pautier P; Duvillard P
    Int J Gynecol Cancer; 2004; 14(2):395. PubMed ID: 15086746
    [No Abstract]   [Full Text] [Related]  

  • 17. Tamoxifen and endometrial lesions.
    Neven P
    Lancet; 1993 Aug; 342(8869):452. PubMed ID: 8102426
    [No Abstract]   [Full Text] [Related]  

  • 18. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine sarcoma after tamoxifen therapy for breast cancer.
    Samuji M; O'Sullivan R; Shireen R
    Ir Med J; 2013 Sep; 106(8):246. PubMed ID: 24282897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobular breast cancer metastasis to uterus during adjuvant tamoxifen treatment: A case report and review of the literature.
    Aytekin A; Bilgetekin I; Ciltas A; Ogut B; Coskun U; Benekli M
    J Cancer Res Ther; 2018; 14(5):1135-1137. PubMed ID: 30197363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.